Navigation Links
Daniel J. Berry, MD, Named Academy Second Vice President
Date:2/27/2009

LAS VEGAS, Feb. 27 /PRNewswire-USNewswire/ -- Orthopaedic surgeon Daniel J. Berry, MD, was elected to the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/) Board of Directors at the 2009 Annual Meeting. He will serve the Academy as Second-Vice President.

"Being an orthopaedic surgeon gives me the opportunity to have a dramatic positive effect on patients' lives," explained Dr. Berry. "I am humbled and honored to serve in this leadership role. I also look forward to dedicating myself to the opportunities and challenges the orthopaedic landscape faces."

A graduate of Dartmouth College and Harvard Medical School, Dr. Berry completed orthopaedic surgery residencies at Harvard, Brigham and Women's Hospital and Massachusetts General Hospital. He completed his fellowship at Mayo Clinic in Rochester, Minnesota. Currently, he serves as professor of orthopaedics, College of Medicine at Mayo Clinic and chair in the Department of Orthopaedic Surgery at Mayo Clinic.

Active in the AAOS since 1998, Dr. Berry has served on numerous committees and task forces, including the Academy's American Joint Replacement Registry Oversight Board and the CME Courses Committee. He most recently served as president of the American Association of Hip and Knee Surgeons (AAHKS) and held previous leadership roles for the American Board of Orthopaedic Surgery (ABOS), the Hip Society and the Mid America Orthopaedic Association.

"By participating in orthopaedic organizations and societies, I have had the opportunity to work with, and learn from, a remarkably talented group of individuals who have become some of my life-long friends," said Dr. Berry.

As an orthopaedic researcher, Dr. Berry has received numerous honors and accolades including awards for clinical research from the Hip Society, the Knee Society, the AAHKS, and the Orthopedic Research and Education Foundation (OREF). He is the author or co-author of over 117 peer-reviewed publications and 62 book chapters. Dr. Berry has made scientific presentations at over 330 regional, national and international meetings.

Dr. Berry's main focus areas for the AAOS include:

  • Continuing to enhance orthopaedic patient care through innovation and patient advocacy.
  • Maintaining and expanding relationships with each of the orthopaedic specialty societies, sister U.S. and international orthopaedic organizations and societies.
  • Advancing quality orthopaedic care and orthopaedic education for each of our members.

"Dan represents all the qualities that the AAOS is looking for in the leadership of the Academy," stated John Callaghan, MD, incoming first vice president of the AAOS. "There is no one I know who represents a leader more than Dan."

When not in the operating room or seeing patients, Dr. Berry enjoys the outdoors and traveling. He is an avid fly fisherman and downhill and cross country skier. He spends any free time with his wife, Camilla, and two children, Charlotte and John.

More about Daniel J. Berry, MD

(http://mayoresearch.mayo.edu/mayo/research/staff/berry_dj.cfm)

About AAOS

(http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=40&releasenum=735)

    For more information, contact:

    Catherine Dolf
    (O) 847-384-4034
    (C) 847-894-9112
    dolf@aaos.org

    Lauren Pearson
    (O) 847-384-4031
    (C) 224-387-8610
    lpearson@aaos.org



'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
2. Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards
3. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
4. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
5. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
6. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
7. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
8. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
9. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
10. Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
11. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: